Terms: = Colorectal cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Clinical Outcome
593 results:
1. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
2. Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.
Jing ZL; Liu GL; Zhou N; Xu DY; Feng N; Lei Y; Ma LL; Tang MS; Tong GH; Tang N; Deng YJ
Sci Rep; 2024 Mar; 14(1):6053. PubMed ID: 38480774
[TBL] [Abstract] [Full Text] [Related]
3. Application Value of High-Quality Nursing in Operating Room in Rectal cancer Operation and its Influence on Postoperative Rehabilitation.
Liu J; Tan F; Zhang Y; Zhou P; Qian Q; He Q; Xu J
Surg Innov; 2024 Jun; 31(3):274-285. PubMed ID: 38468453
[TBL] [Abstract] [Full Text] [Related]
4. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
[TBL] [Abstract] [Full Text] [Related]
5. [clinical outcome of Five Patients with Perforated colorectal cancer].
Jinushi K; Ikenaga M; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1566-1568. PubMed ID: 38303343
[TBL] [Abstract] [Full Text] [Related]
6. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
7. The age-related obesity paradigm: results from two large prospective cohort studies.
Ge YZ; Liu T; Deng L; Zhang Q; Liu CA; Ruan GT; Xie HL; Song MM; Lin SQ; Yao QH; Shen X; Shi HP;
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):442-452. PubMed ID: 38146198
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome.
Yang LP; Jiang TJ; He MM; Ling YH; Wang ZX; Wu HX; Zhang Z; Xu RH; Wang F; Yuan SQ; Zhao Q
Cell Rep Med; 2023 Oct; 4(10):101222. PubMed ID: 37794586
[TBL] [Abstract] [Full Text] [Related]
9. Delayed-Onset Organ/Space Surgical Site Infection Worsens Prognosis in High-Risk Stage II and III colorectal cancer.
Okui J; Shigeta K; Kato Y; Mizuno S; Sugiura K; Seo Y; Nakadai J; Baba H; Kikuchi H; Hirata A; Makino A; Kondo T; Matsui S; Seishima R; Okabayashi K; Obara H; Sato Y; Kitagawa Y
J Gastrointest Surg; 2023 Nov; 27(11):2515-2525. PubMed ID: 37740145
[TBL] [Abstract] [Full Text] [Related]
10. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract] [Full Text] [Related]
11. Similar success rate in proximal and distal colonic stent placement: a retrospective multi-center study.
Basiliya K; Galanopoulos M; Papaefthymiou A; Webster G; Carroll N; Fearnhead NS; Corbett G
Scand J Gastroenterol; 2024; 59(1):108-111. PubMed ID: 37694882
[TBL] [Abstract] [Full Text] [Related]
12. Immune Marker Spatial Distribution and clinical outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
[TBL] [Abstract] [Full Text] [Related]
13. Technique, sedation, and clinical outcome of endoscopic submucosal dissection for rectal tumor with involvement of dentate line: A retrospective cohort study.
Noh YK; Lee J; Kim SJ
Saudi J Gastroenterol; 2023; 29(6):365-370. PubMed ID: 37282445
[TBL] [Abstract] [Full Text] [Related]
14. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
Ryoo SB; Heo S; Lim Y; Lee W; Cho SH; Ahn J; Kang JK; Kim SY; Kim HP; Bang D; Kang SB; Yu CS; Oh ST; Park JW; Jeong SY; Kim YJ; Park KJ; Han SW; Kim TY
Br J Cancer; 2023 Aug; 129(2):374-381. PubMed ID: 37280413
[TBL] [Abstract] [Full Text] [Related]
15. Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.
Hou J; Zhao R; Gronsbell J; Lin Y; Bonzel CL; Zeng Q; Zhang S; Beaulieu-Jones BK; Weber GM; Jemielita T; Wan SS; Hong C; Cai T; Wen J; Ayakulangara Panickan V; Liaw KL; Liao K; Cai T
J Med Internet Res; 2023 May; 25():e45662. PubMed ID: 37227772
[TBL] [Abstract] [Full Text] [Related]
16. Tumour infiltrating lymphocytes in colorectal cancers- correlation with tumour biology and clinical outcome: A cohort study.
Mangi FH; Shaikh TA; Qureshi JN; Ujjan ID; Syed BM
J Pak Med Assoc; 2022 Nov; 72(11):2193-2197. PubMed ID: 37013285
[TBL] [Abstract] [Full Text] [Related]
17. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
[TBL] [Abstract] [Full Text] [Related]
18. Feasibility of [
Bae SW; Wang J; Georgiou DK; Wen X; Cohen AS; Geng L; Tantawy MN; Manning HC
Tomography; 2023 Feb; 9(2):497-508. PubMed ID: 36961000
[TBL] [Abstract] [Full Text] [Related]
19. clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
Paszt A; Ottlakan A; Abraham S; Simonka Z; Vas M; Maraz A; Szepes Z; Tiszlavicz L; Nyari T; Olah J; Lazar G
Pathol Oncol Res; 2022; 28():1610722. PubMed ID: 36567978
[No Abstract] [Full Text] [Related]
20. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
[TBL] [Abstract] [Full Text] [Related]
[Next]
